The Buda Health Center is one of the leading private institutions of Budapest offering its patients personalized comprehensive health care.

Magyar

Dömötör, Eszter, MD Ph.D.

 

Medical specialism

  • Therapy of anxiety and depression

Professional experience

  • 1994 – 2001: Department of Medical Biochemistry, Semmelweis University
    • 1994 – 1997: Ph.D. student
    • 1997 – 2000: Medical intern
    • 2000 – 2001: Academic assistant
  • 2001 – 2003: Division of Neurovascular Biology, Frank Smith Laboratories for Neurosurgery, University of Rochester
    • Postdoctoral scientific colleague
  • 2003 – 2006: Department of Psychiatry and Psychotherapy, Semmelweis University
    • Internship
  • 2006 – 2007: Kútvölgyi Clinical Block, Semmelweis University
    • Psychiatrist specialist candidate
  • 2007 – 2011: Department of Psychiatry, Szent János Hospital and North Buda United Hospitals
    • Psychiatrist
  • 2008 – : Private practice
  • 2008 – : Buda Health Center
    • Private practice
  • 2011 – 2014: Mental Health Clinic, Medical Non-profit Kft. of Újpest
    • Psychiatrist
  • 2016 – 2017: 1st Department of Psychiatry and Psychiatric Rehabilitation, Jahn Ferenc Hospital of South Pest
    • Head of Department
  • 2014 – 2016, 2017 – : Psychiatric Clinic, Medical Institute of XV. District’s Local Government
    • 2014 – 2016: Head of Department
    • 2017 – : Senior doctor

Education and qualifications

  • 1994: Faculty of Medicine – Semmelweis University
  • 2000: Ph.D., Neuroscience, Semmelweis University
  • 2008: qualifying exam in psychiatry
  • 2010: psychodramatic course
  • 2017: hypnotherapy course

Language skills

  • English

Scientific activity

  • Dömötör E, Hermánné EF. “Comparison of antidepressant effect of agomelatine and escitalopram in major depression: a retrospective investigation at a psychiatric outpatient clinic.” kézirat General Med. 2016.
  • Domotor E, Hermanne EF.” [The temporal accuracy of agomelatine administration and comparison of antidepressant effect of agomelatine and escitalopram in major depression: a retrospective investigation at a psychiatric outpatient clinic]. Az gomelatinszedés pontossága és az agomelatin- escitalopram antidepresszív hatásának összehasonlítása major depresszióban: retrospektív vizsgálat a pszichiátriai szakrendelő betegeinél. Az ördög a részletekben rejlik,” Neuropsychopharmacol Hung. Jun;17(2):59-67. 2015. 
  • Hejjas K, Szekely A, Domotor E, Halmai Z, Balogh G, Schilling B, Sarosi A, Faludi G, Sasvari-Szekely M, Nemoda Z. “Association between depression and the Gln460Arg polymorphism of P2RX7 Gene: A dimensional approach.” American Journal of Medical Genetics B Neuropsychiatr. Genet. 150B(2):295-9 2009.
  • Halmai Z, Dömötör E, Balogh G, Sárosi A, Faludi G, Székely A. “Validation of a new mood questionnaire on a healthy sample.” Neuropsychopharmacol. Hung;10(3):151-7. Hungarian 2008.
  • Sarosi A, Gonda X, Balogh G, Domotor E, Szekely A, Hejjas K, Sasvari-Szekely M, Faludi G. “Association of the STin2 polymorphism of the serotonin transporter gene with a neurocognitive endophenotype in major depressive disorder.” Prog Neuropsychopharmacol Biol Psychiatry. Jul 3, 2008. 
  • Dömötör E, Sárosi A, Balogh G, Székely A, Héjjas K, Sasvári-Székely M, Faludi G.
    “Association of neurocognitive endophenotype and STin2 polymorphism in major depressive disorder” Neuropsychopharmacologia Hungarica (2):53-62. 2007.
  • Hejjas K, Domotor E, Szekely A, Balogh G, Sarosi A, Faludi G, Sasvari-Szekely M. “Case-control study of serotonin transporter polymorphism in major depressive disorders.” American Journal of Medical Genetics B Neuropsychiatr.Genet. 141B (7): 741-741, 2006.
  • Faludi G, Domotor E, Balogh G, Sarosi A, Szekely A, Hejjas K, Sasvari-Szekely M. “Association between the STIN2 but not the 5-HTTLPR polymorphism of the serotonin transporter and major depressive disorder.” Int. J. Neuropsychopharmacology 9: S176-S176 Suppl. 1 2006.
  • Domotor, E., Benzakour, O., Griffin, JH., Fukudome, K. Yule, D. and Zlokovic BV. “Activated Protein C alters cytosolic Ca2+ in human brain endothelium via binding to endothelial protein C receptor and activation of Protease-Activated Receptor-1”. Blood 101(12) 4797-4801, 2003. IF: 10,12
  • Dömötör, E., Bartha, K., Machovich, R. and Adam-Vizi, V. “Protease-activated receptor-2 (PAR-2) in the brain microvascular endothelium and its regulation by plasmin and elastase.” Journal of Neurochemistry 80, 746-754, 2002. IF: 4,97
  • Sipos, I., Dömötör, E., Abbott, NJ. and Adam-Vizi, V. “The pharmacology of nucleotide receptors on primary brain endothelial cells grown on a biological extracellular matrix: effects on intracellular calcium concentration.” British Journal of Pharmacology 131, 1195-1203, 2000. IF: 3,69
  • Bartha, K., Dömötör, E., Lanza, F., Adam-Vizi, V. and Machovich, R. “Identification of thrombin receptors in rat brain capillary endothelial cells.” Journal of Cerebral Blood Flow and Metabolism 20, 175-182, 2000. IF: 5,93
  • Dömötör, E., Abbott, NJ. and Adam-Vizi, V. “Na+-Ca2+ exchange and its implication for calcium homrostasis in primary cultured rat brain microvascular endothelial cells.” Journal of Physiology (London) 515, 147-155, 1999. IF:4,552
  • Dömötör, E., Sipos, I., Kittel, A., Abbott, NJ. and Adam-Vizi, V. “Improved growth of cultured brain microvascular endothelial cells on glass coated with a biological matrix”. Neurochemistry International 33, 473-478, 1998. IF:1,781


Should You like to make an appointment with our collegue for private consultation, please dial the number +36-1-489-5200, where our dispatchers will answer your call between 8am and 8pm every weekday!